�y��vlog

Benralizamab is a monoclonal antibody which targets specific white blood cells, called eosinophils, to reduce lung inflammation.

Benralizumab targets a type of white blood cell - called an eosinophil - that can cause inflammation and damage in the lungs.

Their biological roles are poorly understood, but recent studies suggest that eosinophils are involved in regulating our fat metabolism, repairing certain tissues, and helping us fight different infections and cancers.

Benralizumab is a biologic therapy that reduces the number of inflammatory cells called eosinophil.

The disease is linked to an elevated level of white blood cells called eosinophils — the cells that respond in allergic reactions.